An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

An innovative diagnostic strategy for the detection of rare molecular targets to select cancer patients for tumor-agnostic treatments

Published:2019-12-10 Issue:65 Volume:10 Page:6957-6968
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Marchetti Antonio¹²³,Di Lorito Alessia²,Felicioni Lara³,Buttitta Fiamma¹²³

Affiliation:

1. Laboratory of Diagnostic Molecular Oncology, Center for Advanced Studies and Technology (CAST), University of Chieti, Chieti, Italy

2. Department of Medical and Oral Sciences and Biotechnologies, University of Chieti, Chieti, Italy

3. Department of Pathology, SS Annunziata Clinical Hospital, Chieti, Italy

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tumor-Agnostic Therapy—The Final Step Forward in the Cure for Human Neoplasms?;Cells;2024-06-20

2. Efficient Identification of Patients With NTRK Fusions Using a Supervised Tumor-Agnostic Approach;Archives of Pathology & Laboratory Medicine;2023-06-01

3. NTRK Gene Fusions in Non-Small-Cell Lung Cancer: Real-World Screening Data of 1068 Unselected Patients;Cancers;2023-05-29

4. Getting Your Laboratory on Track With Neurotrophic Receptor Tyrosine Kinase;Archives of Pathology & Laboratory Medicine;2022-12-12

5. NTRK gene fusions in solid tumors: agnostic relevance, prevalence and diagnostic strategies;Pathologica;2022-06

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP